Alzheimer’s disease (AD) is a neurodegenerative disease that causes brain cell death. This progressive disease, which causes a distinct pattern of pathological changes in the brain, is most common ...

Alzheimer's disease is a multifactorial neurodegenerative disorder, characterized by amyloid plaques, neurofibrillary tangles, and gliosis. Beyond genetic and age-related factors, diverse risk ...

(CNN) — Alzheimer’s disease is increasingly widespread, affecting more than 55 million people worldwide — a figure that’s expected to nearly triple by 2050. (CNN) — Alzheimer’s disease is increasingly ...

In the brain, Alzheimer’s is characterized by two proteins, amyloid beta and tau, that become dysfunctional, forming plaques ...

SEVEN NEWS. MORE THAN 53,000 NEW MEXICANS ARE EXPECTED TO HAVE ALZHEIMER’S DISEASE BY 2025. THE ALZHEIMER’S ASSOCIATION SAYS THAT’S AN INCREASE OF 2000 PEOPLE PER YEAR. WE ASKED KOAT, UNM HEALTH ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the ...

Medications like lecanemab (Leqembi) and donanemab (Kisunla) target amyloid plaques in the brain that build up due to Alzheimer’s disease. They may help slow disease progression for people in the ...

Alzheimer's disease often begins many years before memory problems appear. During that silent phase, toxic changes slowly build inside the brain. For decades, scientists focused mostly on amyloid ...

This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. Alzheimer’s disease has proved to be a ...

Dr. Solomon Carter Fuller, the first Black psychiatrist in the United States, contributed to early research on Alzheimer’s disease. - Boston University Photography Alzheimer’s disease is increasingly ...

(CNN) — Alzheimer’s disease is increasingly widespread, affecting more than 55 million people worldwide — a figure that’s expected to nearly triple by 2050. Despite the disease’s prevalence, few know ...